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ATTEMPTS are being made to investigate whether proteolytic enzymes, possibly
liberated from the tumour cells, are implicated in the observed extracellular
proteolysis offibrous host proteins at the periphery ofmalignant tumours (Sylven,
1945 and 1954; Sylven and Malmgren, 1957). The solid mouse tumour materials
did not, until very recently, allow separate sampling of the extracellular fluid
for enzymic assays. Therefore, the ascites tumour material was chosen since in
this case an extracellular fluid compartment could easily be sampled. The present
line of approach is supported by some recent evidence that malignant cells in
general are more permeable than normal non-malignant cells in the sense that
cytoplasmicproteinsandenzymesare more freelypassing out ofthe cellmembranes.
The particular physiological conditions and states of adaptation favouring such
a liberation are not yet understood.
This report summarizes serial data on the total "over-all" dipeptidase and
acid proteinase activities of (a) the ascites tumour cells, (b) the cell-free ascites
fluid, and (c) the corresponding blood plasma activity levels in the same tumour-
bearing mice. The particular acid proteinases of normal blood plasma active in
the pH range 2 to 6 have been tentatively characterized as belonging to the
pepsin and cathepsin groups (Mirsky et al., 1952). The changes in plasma dipep-
tidase and acid proteinase activities in the course of ascites tumours have been
described (Ottoson and Sylven, 1959). The present results are, however, bur-
dened by several limitations restricting our conclusions. In view of the trans-
port problems involved, the expected more or less non-specific host reactions,
and the dilution effects in the different compartments, more direct evidence is
needed as to the basic permeability problems of the tumour cells referred to
above.
PREVIOUS DATA ON THE PERTINENT ENZYMIC ACTIVITIES
Blood serum and plasma.-It is well known that normal plasma contains a
considerable pool of various peptidases active against commonly tested di- and
tripeptides (Grassmann and Heyde, 1929; Fruton, 1946; Fleisher and Butt,
1953).
The dipeptidase activity ofmouse plasma against alanylglycine (AG) undergoes
a continuous increase in the course ofascites tumour growth (Ottoson and Sylven,
1959). An endopeptidase activity in rabbit serum against benzoylglycineamide
at pH 5.4 was further described by Fruton (1946). In addition, normal mouse
plasma contains at least two types of proteinases with activity optima against
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urea-denatured haemaglobin at pH 3-5 and 4.5 (Fig. 3). These proteinase activities
undergo characteristic changes in the course of ascites tumour growth (Ottoson
and Sylven, 1959).
The total dipeptidase activity referred to above is of a moderate magnitude
in mouse plasma (about 0*2 /tl. 0.1 M. NaOH per ,l. plasma per hour), while
the proteinase activities at pH 3.5 and 4.5 are high (extinctions about 0-15 per
,l. per 90 minutes at 37°) as compared with those of human plasma. The cellular
sources of these enzymes are not known in detail. It seems likely that the pro-
teinase activity at pH 3.5 is due to pepsinogen (activated) from the stomach
mucosa (Mirsky et al., 1952).
Lymph.-Lymph enzymes in general present lower concentrations per volume
than blood plasma (Yoffey and Courtice, 1956). The concentration of enzymes
is said to run largely parallel with the concentration of proteins in the larger
lymph trunks so far investigated. A trypsin-like proteinase in thoracic duct
lymph of the dog was described by Osato (1921), and a dipeptidase in rabbit leg
lymph by Ishino (1935/38). The enzymic content of the smaller efferent lymph
channels is not known; however, according to Doyle (1955), lymph from the
appendix has a slightly higher peptidase level than blood plasma. No data on
the content of acid proteinases are available.
Interstitial tissue fluid.-Little is known of the enzymal activities in the
interstitial fluid of normal tissues. The concentrations are expected to be of a,
similar order of magnitude as that in lymph. An aminopeptidase activity has
been observed by histochemical methods in the oedema fluid of skin disorders
in man (Braun-Falco, 1957), and also at the periphery of several malignant
tumours (Burstone, 1956). A proteinase activity was long ago postulated to
occur in the extracellular fluid of healing wounds explaining the removal of pre-
formed fibrous proteins. It is not known, however, whether these activities
are due to cell damages or if they occur also under normal in vivo conditions.
It was cursorily mentioned by Libenson and Jena (1957) that the cell-free tissue
fluid within certain transplanted human tumours contained a greater proteolytic
activity at pH 4 than thenormal subcutaneous tissue fluid distant from the tumour
site. Quantitative assays of the peptidase and catheptic activities of the extra-
cellular fluid taken in vivo from various solid mouse tumour transplants (Sylven,
unpublished) distinctly indicate that these activities per unit volume are con-
siderably higher than the levels observed in normal lymph and plasma.
Preliminary data on the normal peritoneal fluid collected by capillary tech-
niques from the intact peritoneal cavity of the same strain of inbred mice, as
used in this report, are being collected. Samples pooled from a large number of
mice showed a rather high total dipeptidase figure (about 4 times the correspond-
ing plasma activity). The pH 3-5 and 4.5 proteinase activities against urea-
denatured haemoglobin were of the same order as those of the corresponding
blood plasma. The relative activities are for comparison included in Fig. 7.
Ascites tumourfluid.-The dipeptidase activity in the fluid of mouse ascites
tumours was reported to be low (Malmgren, Sylven and R6vesz, 1955). The
presence of a carboxypeptidase inhibitor in the fluid was demonstrated by Fein-
stein and Ballin (1953), and later on also noted against the AGpeptidase by Malm-
gren, Sylven and Revesz (1955). With reference to the proteinase activities in
ascites tumour fluid little is known. Spontaneous hydrolysis (pH unknown)
ofthe inherent proteins did not occur during two hours' incubation time according
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to Christensen and Riggs (1952); this possibly excludes the presence of marked
tryptic activities. Malmgren, Sylven and Revesz (1955) cursorily mentioned that
a low proteinase activity was noted against nitrocasein and edestin at pH 5.3
and 3.8, respectively. The method used at that time was rather insensitive and
therefore no significant changes in the proteinase activity were noted in the course
of the ascites tumour growth. More data are available on the presence of other
hydrolytic and glycolytic enzymes in the ascites fluid (Warburg and Christian,
1943; Kun, Talalay and Williams-Ashman, 1951; Schade, 1953; Wuand Racker,
1958; Bosch, 1958).
Ascites tunour cells.--The peptidase activities against four tested dipeptides
and one tripeptide have been described in homogenates from three different
ascites tumour cell strains (Malmgren, Sylven and Revesz, 1955). Serial data on
the tumour cells at different times after inoculation indicated that the dipeptidase
activity was proportional to the protein content of the cells. During the same
time the average catheptic activity per tumour cell at pH 3-8 against acid-
denatured haemoglobin remained low and fairly constant. A more detailed study
of the cellular proteinases of tumours was recently published (Sylven and Malm-
gren, 1957). The present report supplements previous ascites tumour data men-
tioned above.
MATERIALS AND METHODS
Mice.-Male backcross mice were used, produced by mating males ofthe DBA
strain with (C3H x DBA)F1 hybrid females. The animals were 3 to 4 months
oldandweighed 16-22g. Theyweregiven astandard compressed dietanddrinking
water ad libitum.
Tumour strain.-The hyperdiploid Ehrlich ascites tumour was employed,
referred to as ELD (Bayreuther, 1952; Hauschka et al., 1957). The tumour has
been maintained by weekly serial ascitic transfers in DBA x (DBA x C3H)
backcross mice. The transfers were carried out routinely by injecting 0-1 ml. of
the undiluted ascitic fluid intraperitoneally.
Measurement of ascites tumour growth.-The total volume of peritoneal fluid
and the total number of tumour cells was measured by determining the dilution
of an intraperitoneally injected dye (bromosulphthalein), together with total
and differential cell counting and determination of the packed cell volume. The
details of this procedure have been described by Revesz and Klein (1954).
Sampling.-Each experiment was performed with ascites fluid and cells
pooled from three identically treated mice in such a way that each mouse contri-
buted an equal volume of ascites fluid and an equal number of cells. Pooled
material was used in order to avoid most ofthe individual variations. The ascites
fluid and cells was taken out in 3.5 per cent sodium citrate to 1/5 of the total
sample volume. The fluid and the cells were separated before pooling by centri-
fugation for 10 minutes at about 600-800 x g. The first supernatant was further
centrifuged for 10 minutes at about 6000 x g in order to remove all cell debris.
Some fluid samples were carefully controlled under the phase-contrast micro-
scope and no cell elements remained. After pooling, the supernatants were diluted
2 to 5 timeswith a 0-05 percent aqueous solution ofsodium deoxycholate according
to our standard procedure (Sylven and Malmgren, 1957).
The cells were washed twice in saline and then resuspended in twice their
volume of saline. After counting the number of cells in each sample they were
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pooled as described above. The pooled cell suspension was homogenized for 15
minutes under cooling. Sodium deoxycholate was added to obtain a suitable
concentrationandthemixture wasleftto extract forone hour at room temperature.
A cell concentration corresponding to 80 x 106 per ml. was used for the proteinase
assays and 2 to 4 x 106 per ml. for the dipeptidase tests.
The average ascites cell volume ofthe packed cells has been 25 per cent ofthe
total ascites volume. This figure has been used for the calculation of the fluid
content obtained by centrifugation.
Enzymic assays.-The dipeptidase assays by titration according to the modi-
fication of the Linderstrom-Lang and Holter method have been described by
Sylv6n and Malmgren (1957). Since the ascites peptidases may be activated by
magnesium ions, MgSO4 has been added to a final concentration of 0.006 M.
The proteinase determinations using urea-denatured bovine haemaglobin as
a substrate have been made according to Ottoson and Sylv6n (1959). All samples
have been assayed both with and without the addition of cysteine to a final con-
centration of 0.003 M.
Since the enzymic activity data of the fluid compartments are discussed as
matters of transport equilibria all results are primarily given per /l. fluid.
Protein determination.-The protein contents have been assayed in triplicate
tests with a micro-Kjeldahl method. The standard deviation among tests per-
formed on the same material was of the order of 3 per cent and the error of the
mean ofthe three tests was ofthe order of 2 per cent.
RESULTS
The multiplication of the ELD ascites tumour cells was determined in two
separate experiments each comprising 30 mice inoculated with 20 x 106 tumour
cells. At daily intervals, two mice were killed and the geometric mean was calcu-
lated for each lot of total cell numbers, cell concentrations per ml. ascitic fluid,
and amount of cell-free ascitic fluid (four individual determinations from two
separate experiments). Some data of this series have been published earlier
(Hauschka et al., 1957).
Fig. 1A shows the increase in total number and concentration of free tumour
cells in the ascitic fluid during 12 days of growth after inoculation. The growth
of the ELD cells is characterized by a continuously increasing generation time.
The decrease in thegrowth rate proceeds smoothly and thenumber of free tumour
cells continues to increase until a total number of about 109 cells is reached. The
concentration of the tumour cells per ml. fluid remains largely constant during
the major part of the growth cycle and shows only a moderate random variation
around a value of about 200 x 106 cellsper ml. ascites. Fig. lB shows the increase
in the amount of the cell-free ascitic fluid. Since the mean volume of the ELD
cells has been foundto be fairly constant (about 1360 cubic,/) due to the constancy
of the cell concentration, the increase in the amount of the cell-free ascitic fluid
is directly proportional to the increase ofthe total number oftumour cells.
The previously reported increase in the average amount of protein per cell,
as observed in the ELD and Krebs 2 ascites tumours (Malmgren, Sylv6n and
R6v6sz, 1955), was corroborated also in this series ofthe ELD strain. The protein
figure rose from an average of 1.4ltg. per 10,000 tumour cells, at the fourth day
after inoculation, until about 2-8 micrograms at the eighth day, which is at
variance with data by Ledoux and Revell (1955).
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Protein content of blood plasma and ascites ftuid.-In our stock of mice the
plasma protein concentration went down from a normal level close to 6 per cent
to below 4 per cent in the course of the ascites tumour growth (Fig. 2). This
figure also shows that the protein concentration of the cell-free ascites fluid
declines from about 4-5 per cent to about 2-5 per cent at the end of the growth
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Fic. 1.-Changes in the tuimour cell numbers and ascites fluid volume plotted against the
time after tumour inoculation (cf. data by Hauschka et al,. 1957).
1, A.-Average total tumour cell numbers X -- x -X
Tumour cell concentration 0- 0 -O
1, B. Volume of cell-free ascites fluid x- x - X
Total volume of ascites 0- 0--O
curve. Ledoux and Revell (1955) previously found in the same strain of ascites
tumours an increasing protein concentration in the fluid up to about 2 per cent
at the 14th day ofgrowth. The protein content of normal rabbit lymph (hind leg)
is about 2.6 per cent (Benson, Kim and Bollmann, 1955) and of human ascites
fluid in cases ofliver cirrhosis about 3 per cent (Schoenberger et al., 1956).
Albumin-globulin ratio of the ascites fluid.-The relative amounts of albumin
and globulins assayed by the electrophoretic method* were as follows:
Albumill Globulins
(%) (%) A/G ratio
Normal male mouse plasma (inbred stock) . . 43 57 0- 75
Plasma of ascites tumour-bearing male mice . 50 . 50 1.0
Ascites tumour fluid . . . . 56 44 1-25
* The determinations have kindly been made in the laboratory of Dr. B. Olhagen, at the Rheumatic
Clinic, Karolinska Hospital, Stockholm.
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The relative excess ofthe albumin fraction in the ascites fluid agrees with the
figure of Kun et al. (1951), who found about 58 per cent albumin in pooled Ehrlich
ascites tumour fluid. The A/G ratio in the ascites fluid is thus 1-25, which is
significantly larger than that of normal mouse plasma.
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FIG. 2.-The change in protein content of mouse blood plasma and cell-free ascites tumour
fluid with the time after inoculation. Each figure obtained from samples pooled from
three mice (see text).
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FIG. 3.-The pH-activity curve of normal mouse plasma using urea-denatured haemoglobin
as a substrate; cysteine added (see text). All extinctions are given per ,il. plasma. The
above activity optima will become displaced to the left when acid-denatured haemoglobin
is used (Ottoson and Sylv6n, 1959).
Enzymic activities of the ascites fluid and tumour cells.-From about the 12th
day of ascites tumour growth the dipeptidase activity ofthe ascites fluid rapidly
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increased (Tables I and III). This activity ofascites fluid did coincide with the
late increase in dipeptidase activity of the blood plasma of the same tumour-
bearing mice (Ottoson and Sylven, 1959). Maximum activity figures (in the pre-
sence ofthe dipeptidase inhibitor, previously mentioned) at the end ofthe growth
period were equivalent to about 1-8 jpl. NaOH, which is more than three times
the corresponding plasma level. The recorded extracellular activity constitutes
from 0.5 to 4 per cent of the total activity contained per ul. ascites inclusive of
the tumour cells.
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FIG. 4.-The pH-activity curve of the acid proteinases of washed ascites tumour cells pooled
from three mice on the fifth day of tumour growth. Substrate urea-denatured haemo-
globin; cysteine added. Extinctions expressed per 106 cells.
In the case of the proteinases active in the pH range of 2 to 6 the conditions
are more complicated. In normal mouse plasma there are at least two (possibly
three) proteinases, which show optimum activity against urea-denatured haemo-
globin at pH 3.5 (3.5 enzyme) and 4.5 (4.5 enzyme) (Ottoson and Sylven 1959;
Fig. 3). The first one is probably a pepsin-like enzyme (Mirsky et al., 1952), while
part of the second one is expected to be of cathepsin nature. The acid proteinases
of lymph have not been studied. It may further be added that the extracellular
fluid obtained in diluted form from washings of the peritoneal cavity of normal
mice also contains two proteinase activity peaks of about equal magnitude at
pH 3.5 and 4.5 against urea-denatured haemoglobin (unpublished data). The
shape of this pH-activity curve is rather similar to that of blood plasma, but
distinctly different from that ofthe tumour ascites fluid (Fig. 5) mentioned below.
In the interstitial fluid of solid mouse tumour transplants two proteinase peaks
have also been observed at about pH 3.8 and anotherat 4.5-4.7 (Sylven, unpub-
lished data). The pH-dependence of the ascites tumour cell proteinases is shown
in Table I and Fig. 4, which demonstrate that the pH 3.5 enzyme is lacking,
38
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while, instead, enzymes of the cathepsin group with optimum activity around
pH 4-5 are present. On the whole, the cathepsin activity is low in the tumour
cells (Malmgren, Sylven and Revesz, 1955; Sylven and Malmgren, 1957). The
appearance of some pH 3.5 proteinase in the tumour cell homogenates at the end
of the growth period (Table I) is considered to be caused by an admixture of
proteins from the ascites fluid not removed by our saline washing.
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FIG. 5.-The pH-activity curve of acid proteinases contained in fresh cell-free ascites fluid.
Conditions the same as in Fig. 3. Data from three pooled samples of five days old
( x x - x) and twelve days old (- - - -0) ascites tumours.
TABLE I.-Serial Data on the Total DipeptidaBe and Proteinase Activity of
Ascites Tumour Cells
Each figure obtained on materials pooled from 3 inbred male mice.
Dipeptidase activity
(pl1. 0-1 M NaOH
per 104 cells
0-7
2-9
2-5
2-0
Proteinase activity
Extinction increase per 106 cells
Cysteine added Cysteine not added
· '
'- · r '
pH 3.5 pH 4-5 pH 3.5 pH 4-5
E E E E
0-15 0-30 0-02 0-32
0-00 0-94 -
0-00 0-84 0-07 0-70
0.00 2-10 0-14 2-16
0.09 0-72 0-15 0-64
0-14 1-46 0-23 1-60
The ascites tumour fluid, on the other hand, shows certain changes in the pH
distribution curve as compared with that of normal mouse blood plasma. During
the early phase oftumour growth the pH 1-8-3-5 enzymes are depressed in activity
or almost lacking (Fig. 5 and 6), while a 4-5 enzyme of cathepsin-type (thermo-
Age of
tumour
(in days)
4
5
7
9
12
16
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and acid-labile) is distinguished. In the course of the later stages of tumour
growth thepH distribution gradually changes, more ofthepH 3.5 enzyme appears,
and further the ratio between the extinction maxima at 3-5 and 4-5 is quite
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FIG. 6.-The observed variations in the acid proteinase activity of fresh cell-free ascites
fluid at the pH optima 3.5 and 4*5. Each figure obtained from three pooled samples.
Activities expressed per ul. fluid (6, A) as well as per ,ug. protein content (6, B).
different as compared with that in the blood plasma. Fig. 6, A and B, demonstrate
the continuous increase in both activities in the later course of ascites tumour
growth. The pH 3-5 enzyme in the ascites fluid does not reach the correspondingB. SYLVEN. R. OTTOSON AND L. REVESZ
plasma level of tumour-bearing mice at the end of tumour growth (Ottoson and
Sylven, 1959).
TABLE II.-Serial Data on the Dipeptidase and Proteinase Activity per ,ul.
Ascites Fluid Pooledfrom 3 Inbred Male Mice
Proteinase activity
Extinction increase per ul. fluid
Dipeptidase activity
(pl1. 0- 1 M NaOH
per ul. fluid)
0 53
0-43
0.31
0-74
1-8
(
Cysteine added
pH 3-5 pH 4.5
E E
0.01 0*12
0.00 0.32
0-01 0-18
0*07 0-58
0.14 0*36
0-17 0-48
Cysteine not added
pH 3-5 pH 4-5
E E
0.01 0-08
0-03 0-14
0-08 0-52
0-15 0-30
0*22 0-54
TABLE III.-Serial Data on the Dipeptidase and Proteinase Activity per
Protein Content in Ascites Fluid Pooledfrom 3 Inbred Male Mice
Dipeptidase activity
(pl1. 0- 1 M NaOH
per mg. protein)
5-4
14-7
9-2
44*6
· 72-0 .
Proteinase activity
Extinction increase per mg. protein
Cysteine added Cysteine not added
pH 3.5 pH 4-5 pH3-5 pH4-5
E E E E
0-2 3.0 0-3 1.8
0.0 11.0 - -
0.5 6-2 1-1 4*6
2-3 17-2 2-5 15-8
4-8 13-0 5*2 10*8
6*7 19*2 8-5 21.0
So far all activities have been expressed per ,l. ascites fluid and plasma. The
observed increases in enzymic activity are still more marked when correlated to
the protein content ofthe compartments (Table III).
DISCUSSION
The observed enzymic data illustrate the net results of a complex series of
transport and permeability events in vivo, which seem difficult to distinguish in
detail. Since the enzymes are unstable and are possibly subject to different degrees
of dilution and inactivation in all the tissue compartments concerned the conclu-
sions are necessarily vague, and have to be supported by other more direct and
independent data. The discussion will mainly be based on the enzymic activities
per unit volume as is usual in problems involving transport stable markers.
Additional information may be obtained by comparing the enzymic activities
on a per-protein basis.
It is further assumed that there is a rapid exchange of water and a slower
exchange of protein constituents between the ascites fluid and blood mainly via
the lymphatic pathways (Courtice and Steinbeck, 1950; Prentice, Siri and Joiner,
1952; Abdou, Reinhardt and Tarver, 1952; McKee et al., 1952; Berson and
Yalow, 1954; and Schoenberger et al., 1956). It is further presupposed that the
Age of
tumour
(in days)
4
5
7
9
12
16
Age of
tumour
(in days)
4
5
7
9
12
16
Per cent
protein
content
4.7
3-9
2-9
3-4
2-8
2-5
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ascites fluid originates from the blood serum (Straube, 1958), but also that certain
ionic and enzymic contributions may appear from the interstitial fluid of the peri-
toneal walls as well as from the intracellular compartment of the peritoneal
cells, normal as well as tumorous ones.
With reference to the exchange of proteins between the blood and ascites
fluid present data seem to justify the conclusion that there is a "restricted
diffusion" of globulins into the peritoneal cavity leading to the observed shift in
the A/G ratio. This might indicate a certain "sieving-effect" on the part of the
capillary membrane.
Days after inoculation peritoneal Days after inoculation
fluid Dy fe nclto
Blood plasma - I Ascites fluid
FIa. 7. Comparison between the enzymal activities expressed per M1l. fluid in the fluid
compartments under question. The plasma data (Ottoson and Sylv6n, 1959) are obtained
on blood samples from the same mice as used in this report. The data on normal peri-
toneal fluid will be published elsewhere.
The relative enzymic activities of the fluid compartments under question are
for comparison compiled in Fig. 7. According to previous concepts it may be
tentatively assumed that the labile extracellular dipeptidase activity is associated
with a relatively small protein molecule of a size close to the albumins, while
the pH 4-5 proteinase activity most likely resides in a larger molecule possibly
of the size of the globulins.
The dipeptidase concentration
In the course of the ascites tumour growth the plasma concentration of total
dipeptidase activity increased to about twice the normal level (Ottoson and Sylv6n,
1959). In the same mice the peptidase activity of the ascites fluid at first, before
the 12th day after inoculation, had a similar concentration (Table II), but then
rose to a maximum level of about three times that of the corresponding blood
plasma activity, and twice that of the normal intraperitoneal fluid (Fig. 7).
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The ascites tumour cells had a very high content of peptidases. The results can
be explained by the assumption that peptidases are diffusing from the tumour
cells into the ascitic fluid and then transported to the blood. The relative balance
between the ascites fluid and blood plasma concentration during the first part
of tumour growth might signify that the exchange is more rapid during this time
(cf. Berson and Yalow, 1954; Straube, 1958) while possibly a relative retention
of peptidases becomes more evident later on. Independent in vitro data (Sylven,
unpublished results) clearly show that the tumour cells are releasing peptidases
at a high rate.
The concentration ofacid proteinases
The proteinase pattern presents a complicated picture. During the first part
of the ascites tumour growth most of the acid proteinase activity was abolished
both in the blood plasma (Ottoson and Sylven, 1959) and in the ascites fluid
(Fig. 7). It is suggested that this may be due to an increased concentration of
acid serum mucoproteins acting as proteinase inhibitiors (cf. above). The pH
3-5 enzyme certainly has some source other than the ascites tumour cells, since the
latter do not contain this enzyme (Fig 4). The enzyme on the other hand is
present in normal peritoneal fluid (unpublished results), although its actual
activity level there is lower than in normal mouse plasma. It is possible that the
pH 3-5 enzyme is derived from the stomach mucosa according to Mirsky et al.
(1952). The present data do not give reliable information as to the actual
concentrations of this enzyme due to the apparent presence of an inhibitor, and
therefore, further discussion is postponed.
The pH 4.5 proteinase is present in the ascites tumour cells (Fig. 4). Also this
enzyme seems to be influenced to some extent by the proteinase inhibitor in the
ascites fluid during the first 5 to 7 days oftumour growth. In some series of mice
the pH 4-5 enzyme shows a moderate activity in the ascites fluid at the 5th to
7th day after inoculation (Fig. 5). The activity then increases to a high level in
the blood plasma as well as in the ascites fluid, although the activity in the latter
compartment remains somewhat higher. On the assumption that the inhibitor
concentration is ofthe same magnitude in both compartments, it appears probable
that a transport of this enzyme occurs from the cells via the ascites fluid to the
blood.
The fate of the peptidases and proteinases possibly transferred to the blood
stream is not known; a certain degree ofinactivation and/or excretion is assumed
to occur. The peptidases are for instance extremely sensitive, and may as well
as the proteinases become excreted similar to its pepsin counterpart. The relative
ratio in plasma between the extinctions of the pH 3-5 and the 4.5 proteinase
activity leaves no indication as to the fate of the pH 4.5 plasma enzyme during
the later part of tumour growth.
It will be noted that the observed differences in enzymic activities per volume
would become increased if the data are recalculated per protein content of the
different compartments (Table III). Since this may not be fully justified with a
view to the transport problems involved, the authors have omitted to consider
this set of data in detail.
The present results do not allow us to consider to what extent a selective
retention of enzymes might contribute to the observed increases of enzymic
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activity in the ascites compartment. The determinations are only an indication
of the actual activities. Since uncontrolled factors are involved and in particular
the presence of a proteinase inhibitor is assumed, the observed activity data do
not represent the total enzyme contents, and cannot serve as indicators of the
amount of blood proteins filtering through from the serum. Present data are
therefore only circumstantial evidence in favour of the view that tumour cells,
as well as normal cells, release enzymes to different extents into the extracellular
fluid.
Thereported in vivoexperiments, however, are insufficient toexplainthefactors
and environmental conditions responsible for the marked enzymic increase at
the end of the ascites tumour growth. It is not known whether this increase is
associated with an increased rate of cell death on the part of the tumour cells.
Acs and Straub (1954) described a very marked increase in the oncentration of
potassium ions in the ascites tumour fluid. This can also be interpreted as an
indication of a release of intracellular K ions into the extracellular space.
The increase in the K ion concentration was noted already very early during
tumour growth, and did not seem to have a close correlation with the frequency
of cell death.
The report illustrates the difficulties involved in the interpretation of data
derived under in vivo conditions, where large differences in enzymic activity are
required before significant results can be obtained on a per-volume basis.
SUMMARY
Quantitative assays were performed of the dipeptidase activity, against
alanylglycine, and proteinase activity between pH 3 to 6, using urea-denatured
haemoglobin as a substrate, in the cell-free ascites fluid of inbred male mice
inoculated with a standard dose of the hyperdiploid Ehrlich ascites tumour.
Comparison was made with previous serial assays, performed in the same mice,
on the corresponding activities of blood plasma.
The quantitative growth characteristics of this ascites tumour line are
described. The protein concentration of the cell-free ascites fluid descreased to
a figure of about 2.5 per cent at the end of tumour growth. The changes in both
the absolute and relative distribution of albumins and globulins in the blood
plasma and ascites fluid of tumour-bearing mice were determined by means of
electrophoresis.
The dipeptidase activity of the ascites fluid showed a continuous increase in
the course of tumour growth, and reached shortly before the animals died a
level of about three times that observed in the corresponding blood plasma. The
pH 3.5 and 4-5 proteinases, normally present in blood plasma, were also demon-
strable in the normal extracellular peritoneal fluid. The pH 3-5 proteinase activity
was almost abolished in the early ascites fluid as well as in the plasma ofthe same
mice. The pH 4-5 activity was simultaneously somewhat depressed. The pH
3.5 proteinase activity later on reappeared in both compartments, but only
reached a level of about half the activity of the corresponding blood plasma. The
pH 4.5 proteinase activity is similar to the intracellular cathepsins. This reached
a high level in the ascites fluid constituting its main proteinase in the acid pH
range. During the same time this activity was increased to twice the normal
level in the blood plasma.
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The conclusion is reached that, most likely, the increase in dipeptidase and
pH 4.5 proteinase activity in the ascites fluid originate by release of enzymal
proteins from intraperitoneal cells. Other independent data to be reported else-
where support the view that most of the released enzymes have leaked out from
the tumour cells.
The results are so far only valid in the case of ascites tumours; the plasma
activities in mice with solid transplanted tumours remain to be studied.
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